Business Maverick, South Africa After the Bell: NHI impasse could hobble second leg of business-government reform partnership by: Ray Mahlaka
Maverick Citizen A dose of their own medicine — should SA force big drugmakers to let others make insulin pens too? by: Christina Pitt
Business Maverick, South Africa, Maverick News Aspen’s Novo Nordisk deal a ‘feather in our cap’ and an NCD battle boost - top executive by: Georgina Crouth
South Africa, Maverick Citizen Aspen’s Covid vaccine facility in Gqeberha switches to making insulin for Africa by: Estelle Ellis
Business Maverick, South Africa, World, Maverick News Latin American market lures SA companies looking to pad out their bottom line by: Neesa Moodley
Business Maverick, South Africa, DM168, Maverick News The Finance Ghost: Mixed fortunes at Sappi, Curro, Aspen, Telkom and Ellies by: The Finance Ghost
Sci-Tech, South Africa, Maverick Citizen SA's pharmaceutical bargaining chip – if you test it here, it must be made available here at a reasonable price by: Claire Waterhouse and Lebohang Kobola
Business Maverick, South Africa, DM168 Where to now for Aspen after vaccine facility sits idle? by: Sasha Planting
Politics, Sci-Tech, South Africa, Media, COVID-19 Exclusive: What Cyril Ramaphosa will say in his 2022 State of the Nation Address by: Ferial Haffajee
South Africa, Maverick Citizen, COVID-19 ‘Don’t wait for Johnson & Johnson vaccine’ — acting director-general of health urges South Africa by: Estelle Ellis